RecruitingNot Applicable

The Study of Urinary Biomarkers in Patients With Hypomagnesemia

United States15 participantsStarted 2025-07-31

Plain-language summary

In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult (≥18 years old) * History of hypomagnesemia (serum Mg \<1.7 mg/dL) Exclusion Criteria: * Current or recent use of loop, thiazide, or thiazide-like diuretics within the last 3 months

What they're measuring

Changes in urinary markers pNKCC2/NKCC2, pNCC/NCC, pSPAK/SPAK, uEGF/Cr, TRPM6, Uromodulin

Timeframe: 2 years

Trial details

NCT IDNCT07056283

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-06

Contact for this trial

Chintan Shah, MD

(352) 294-8790 shahc@ufl.edu

View on ClinicalTrials.gov More Hypomagnesemia trials